United States Influenza Vaccines Market Size, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2031
Table of Contents
1. Introduction
2. Research Methodology
3. Executive Summary
4. United States Influenza Vaccines Market Size, Insights, Analysis, and Forecasts (2018 - 2031)
5. United States Number of Persons Vaccinated with Influenza Vaccines (2018 - 2031)
5.1 Number of Children Vaccinated with Influenza Vaccines
5.2 Number of Adults Vaccinated with Influenza Vaccines
6. Key Market Growth Drivers and Challenges of the United States Influenza Vaccines Market
6.1 Market Drivers
6.2 Market Challenges
7. United States Influenza Vaccines Pricing Analysis, Trends and Insights
8. United States Influenza Vaccines Production, Supply, and Allocation (By Companies),2014 - 2022
9. United States Influenza Vaccines Distribution and Demand Analysis 2010 - 2022
10. Effectiveness of Influenza Vaccines in the United States, 2004 – 2022
11. Rapid Diagnostic Testing for the Management of Influenza
12. Distribution Channel and Technique Detailed Insights of Influenza Vaccination in the United States
13. Reimbursement Environment of the United States Influenza Vaccines Market
14. Regulatory Framework of the United States Influenza Vaccines Market
15. Major Deals and Agreement Activities in the Influenza Vaccines Market
15.1 Merger and Acquisitions
15.2 Collaboration Deals
15.3 Licensing Agreement
15.4 Exclusive Agreement
15.5 Distribution Agreement
16. Promising Influenza Vaccines in the Clinical Development
17. Influenza Vaccines Clinical Trial Insights by Phase, Company and Country
17.1 Year 2022
17.2 Year 2021
17.3 Year 2020
18. Company Profiles
18.1 Sanofi Pasteur
18.1.1 Business Overview
18.1.2 Influenza Vaccines Portfolio
18.1.3 Influenza Vaccines Sales Value Analysis
18.1.4 Promising Influenza Vaccines in the Clinical Development
18.1.5 Recent Development
18.2 GlaxoSmithKline (GSK)
18.2.1 Business Overview
18.2.2 Influenza Vaccines Portfolio
18.2.3 Influenza Vaccines Sales Value Analysis
18.2.4 Recent Development
18.3 Seqirus
18.3.1 Business Overview
18.3.2 Influenza Vaccines Portfolios
18.3.3 Influenza Vaccines Sales Value Analysis
18.3.4 Promising Influenza Vaccines in the Clinical Development
18.3.5 Recent Development
18.4 AstraZeneca
18.4.1 Business Overview
18.4.2 Influenza Vaccines Portfolio
18.4.3 Influenza Vaccines Sales Value Analysis
18.4.4 Recent Development
19. Emerging Company Profiles
19.1 Novavax
19.1.1 Business Overview
19.1.2 Promising Influenza Vaccines in the Clinical Development
19.1.3 Recent Development
19.2 BiondVax Pharmaceuticals Ltd.
19.2.1 Business Overview
19.2.2 Promising Influenza Vaccines in the Clinical Development
19.2.3 Recent Development
19.3 Medicago
19.3.1 Business Overview
19.3.2 Promising Influenza Vaccines in the Clinical Development
19.3.3 Recent Development
19.4 Moderna Inc
19.4.1 Business Overview
19.4.2 Promising Influenza Vaccines in the Clinical Development
19.4.3 Recent Development
19.5 Pneumagen
19.5.1 Business Overview
19.5.2 Promising Influenza Vaccines in the Clinical Development
19.5.3 Recent Development
19.6 Altimmune
19.6.1 Business Overview
19.6.2 Promising Influenza Vaccines in the Clinical Development
19.6.3 Recent Development
19.7 Daiichi Sankyo
19.7.1 Business Overview
19.7.2 Promising Influenza Vaccines in the Clinical Development
19.7.3 Recent Development
19.8 FluGen
19.8.1 Business Overview
19.8.2 Promising Influenza Vaccines in the Clinical Development
19.8.3 Recent Development
19.9 Imutex
19.9.1 Business Overview
19.9.2 Promising Vaccines in the Clinical Development
19.9.3 Recent Development
19.10 EpiVax
19.10.1 Business Overview
19.10.2 Promising Influenza Vaccines in the Clinical Development
19.10.3 Recent Development
19.11 Versatope Therapeutics, Inc.
19.11.1 Business Overview
19.11.2 Promising Influenza Vaccines in the Clinical Development
19.11.3 Recent Development
20. Appendix
20.1 About DPI Research
20.2 Glossary of Terms
List of Tables:
Table 7 1: United States Pediatric Influenza Vaccines Price, 2022 – 2023
Table 7 2: United States Adult Influenza Vaccines Price, 2022 – 2023
Table 8 1: United States Influenza Vaccines Production, Supply, and Allocation
Table 9 1: Total Percentage of Influenza Vaccines Released by Week, 2021 – 2022
Table 9 2: Total Percentage of Influenza Vaccines Released by Week, 2020 – 2021
Table 9 3: Total Percentage of Influenza Vaccines Released by Week, 2019 – 2020
Table 9 4: Total Percentage of Influenza Vaccines Released by Week,2018 – 2019
Table 9 5: Total Percentage of Influenza Vaccines Released by Week,2017 – 2018
Table 9 6: Total Percentage of Influenza Vaccines Released by Week,2016 – 2017
Table 9 7: Total Percentage of Influenza Vaccines Released by Week,2015 – 2016
Table 9 8: Total Percentage of Influenza Vaccines Released by Week,2014 – 2015
Table 10 1: Adjusted Vaccine Effectiveness Estimates for Influenza Seasons, 2004 – 2021
Table 11 1: Influenza Virus Testing Methods
Table 12 1: Distribution of Influenza Vaccination
Table 14 1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 15 1: Merger & Acquisitions in the Influenza Vaccines Market
Table 15 2: Collaboration Deal in the Influenza Vaccines Market
Table 15 3: Licensing Agreement in the Influenza Vaccines Market
Table 15 4: Exclusive Agreement in the Influenza Vaccines Market
Table 15 5: Distribution Agreement in the Influenza Vaccines Market
Table 16 1: BiondVax Pharmaceuticals Ltd. – Clinical Trials
Table 18 1: Sanofi Pasteur Promising Influenza Vaccines in the Clinical Development
Table 18 2: Seqirus Promising Influenza Vaccines in the Clinical Development
Table 19 1: Novavax Promising Influenza Vaccines in the Clinical Development
Table 19 2: Biondvax Promising Influenza Vaccines in the Clinical Development
Table 19 3: Medicago Promising Influenza Vaccines in the Clinical Development
Table 19 4: Moderna Promising Influenza Vaccines in the Clinical Development
Table 19 5: Pneumagen Promising Influenza Vaccines in the Clinical Development
Table 19 6: Altimmune Promising Influenza Vaccines in the Clinical Development
Table 19 7: Daiichi Sankyo Promising Influenza Vaccines in the Clinical Development
Table 19 8: FluGen Promising Influenza Vaccines in the Clinical Development
Table 19 9: Imutex Promising Influenza Vaccines in the Clinical Development
Table 19 10: EpiVax Promising Influenza Vaccines in the Clinical Development
Table 19 11: Versatope Therapeutics, Inc. Promising Influenza Vaccines in the Clinical Development
List of Figures:
Figure 2 1: United States Influenza Vaccines Market Size and Analysis (Million US$),2018 – 2022
Figure 2 2: United States Influenza Vaccines Market Size and Forecast (Million US$),2023 – 2031
Figure 3 1: United States Total Number of Individuals Vaccinated with Influenza Vaccines (Thousand), 2018 – 2022
Figure 3 2: United States Total Number of Individuals Vaccinated with Influenza Vaccines Forecast (Thousand), 2023 – 2031
Figure 3 3: United States Number of Children Vaccinated with Influenza Vaccines (Thousand),2018 – 2022
Figure 3 4: United States Number of Children Vaccinated with Influenza Vaccines Forecast (Thousand),2023 – 2031
Figure 3 5: United States Number of Adults Vaccinated with Influenza Vaccines (Thousand),2018 – 2022
Figure 3 6: United States Number of Adults Vaccinated with Influenza Vaccines Forecast (Thousand),2023 – 2031
Figure 7 1: United States Influenza Vaccine Doses Distributed, By Season (Million),2010 – 2022
Figure 10 1: United States Place of Influenza Vaccination for Children and Adults (Percent),2021 - 2022
Figure 16 1: Sanofi Pasteur Influenza Vaccines Net Sales Value (Million US$),2018 – 2022
Figure 16 2: Sanofi Pasteur Influenza Vaccines Net Sales Value Forecast (Million US$),2023 – 2031
Figure 16 3: GSK Influenza Vaccines Net Sales Value (Million US$),2018 – 2022
Figure 16 4: GSK Influenza Vaccines Net Sales Value Forecast (Million US$),2023 – 2031
Figure 16 5: Seqirus Influenza Vaccines Net Sales Value (Million US$),2018 – 2022
Figure 16 6: Seqirus Influenza Vaccines Net Sales Value Forecast (Million US$),2023 – 2031
Figure 16 7: AstraZeneca Influenza Vaccines Net Sales Value (Million US$),2018 – 2022
Figure 16 8: AstraZeneca Influenza Vaccines Net Sales Value Forecast (Million US$),2023 – 2031
Global BCG Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period.
The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......
Global Peptide Cancer Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 115
According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period.
The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......
Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 26-Dec-2023 Price: US 3380 Onwards Pages: 101
Market Overview of Global Cancer Vaccine market:
According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years.
A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......
Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 12-Dec-2023 Price: US 3380 Onwards Pages: 102
Market Overview of Global Lung Cancer Vaccines market:
According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Lung Cancer Vaccines,A cancer vaccine for lung cance
This report covers a research time span from 2018 to 2028, and ......
Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 07-Dec-2023 Price: US 3380 Onwards Pages: 105
Market Overview of Global Cancer Vaccines market:
According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......
Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 16-Nov-2023 Price: US 3380 Onwards Pages: 110
Market Overview of Global Dendritic Cell Cancer Vaccine market:
According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......
Global BCG Vaccine Market Research Report 2023, Forecast to 2028
Published: 14-Nov-2023 Price: US 2680 Onwards Pages: 135
BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......
Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028
Published: 14-Nov-2023 Price: US 3280 Onwards Pages: 105
BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......
Infectious Vaccine Collaboration and Licensing Deals 2016-2023
Published: 01-Nov-2023 Price: US 3995 Onwards Pages: 300
Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023.
The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs